AllSquare Wealth Management LLC maintained its position in Chimera Investment Co. (NYSE:CIM) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,300 shares of the real estate investment trust’s stock at the end of the first quarter. AllSquare Wealth Management LLC’s holdings in Chimera Investment were worth $329,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Greenleaf Trust increased its position in Chimera Investment by 0.6% in the first quarter. Greenleaf Trust now owns 15,305 shares of the real estate investment trust’s stock worth $309,000 after buying an additional 96 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its position in Chimera Investment by 0.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 65,669 shares of the real estate investment trust’s stock worth $1,118,000 after buying an additional 255 shares during the last quarter. Sheaff Brock Investment Advisors LLC increased its position in Chimera Investment by 1.8% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 23,179 shares of the real estate investment trust’s stock worth $468,000 after buying an additional 400 shares during the last quarter. Sigma Planning Corp increased its position in Chimera Investment by 8.2% in the first quarter. Sigma Planning Corp now owns 15,206 shares of the real estate investment trust’s stock worth $307,000 after buying an additional 1,154 shares during the last quarter. Finally, BlackRock Inc. increased its position in Chimera Investment by 1.4% in the third quarter. BlackRock Inc. now owns 86,599 shares of the real estate investment trust’s stock worth $1,381,000 after buying an additional 1,232 shares during the last quarter. Institutional investors and hedge funds own 53.03% of the company’s stock.
Chimera Investment Co. (NYSE:CIM) traded up 0.56% on Friday, hitting $17.99. The stock had a trading volume of 1,158,608 shares. The firm has a market cap of $3.38 billion, a PE ratio of 5.42 and a beta of 0.74. Chimera Investment Co. has a 12-month low of $14.70 and a 12-month high of $20.90. The company’s 50 day moving average is $19.57 and its 200 day moving average is $18.29.
Chimera Investment (NYSE:CIM) last released its quarterly earnings results on Monday, May 1st. The real estate investment trust reported $0.51 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.07. Chimera Investment had a return on equity of 14.60% and a net margin of 50.90%. The business had revenue of $141.11 million during the quarter, compared to analyst estimates of $140.90 million. During the same quarter last year, the firm posted $0.58 EPS. The company’s revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts expect that Chimera Investment Co. will post $2.37 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, June 30th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 11.18%. The ex-dividend date is Wednesday, June 28th. Chimera Investment’s dividend payout ratio (DPR) is 84.75%.
WARNING: This report was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2017/05/20/chimera-investment-co-cim-stake-maintained-by-allsquare-wealth-management-llc.html.
A number of research firms have recently commented on CIM. Zacks Investment Research downgraded Chimera Investment from a “buy” rating to a “hold” rating in a report on Wednesday, April 19th. Barclays PLC set a $17.00 price objective on Chimera Investment and gave the company a “hold” rating in a report on Monday, May 8th. Finally, Wells Fargo & Co upgraded Chimera Investment from an “underperform” rating to a “market perform” rating in a report on Thursday, February 16th. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Chimera Investment has a consensus rating of “Hold” and a consensus price target of $17.75.
About Chimera Investment
Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities.
Receive News & Ratings for Chimera Investment Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment Co. and related companies with MarketBeat.com's FREE daily email newsletter.